Table 3 Knowledge on difference in ACTs and types of formulations
Characteristic | N (%) |
|---|---|
Type of formulation or packaging* | Â |
Tablet | 23 (37.7) |
Syrup | 16 (26.2) |
Dispersable | 9 (14.8) |
Powder | 6 (9.8) |
Suspension | 4 (6.6) |
Characteristics of ACTs** | Â |
Price | 47 (75.8) |
Appearance | 40 (64.5) |
Therapeutic efficacy | 38 (61.3) |
Mode of action | 27 (43.6) |
Quality | 26 (41.9) |
Individuals who can use them | 25 (40.3) |
Safety | 18 (29.0) |
Ease of use | 3 (4.8) |
Dosage | 3 (4.8) |
Manufacturer | 2 (3.2) |
Side effect profile | 1(1.6) |